HOB Biotech Group Corp Ltd (688656.SS) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · China · ISIN CNE100004C37

Price
99.10 CNY
Market cap
6.27 bn CNY
P/E (2025)
270.35
P/S (2025)
15.74
Dividend yield
0.20 %
Net margin
5.82 %
Return on equity (ROE)
2.83 %
Return on assets (ROA)
2.49 %

HOB Biotech Group Corp Ltd financials

Fiscal year20242025
Revenue402.34 m CNY398.40 m CNY
Gross profit257.18 m CNY232.78 m CNY
Operating income41.38 m CNY26.83 m CNY
EBIT44.07 m CNY24.66 m CNY
Net income36.80 m CNY23.20 m CNY
Diluted EPS – continuing operations0.58 CNY0.37 CNY

Full history since 2016, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About HOB Biotech Group Corp Ltd

HOB Biotech Group Corp.,Ltd. operates as an in vitro diagnostic company in China and internationally. It provides diagnostic tools, such as line immune, enzyme-linked immunosorbent, and chemiluminescent paramagnetic microparticle immune assays to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care. HOB Biotech Group Corp.,Ltd was founded in 2009 and is based in Suzhou, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.